An article in Nature reports how some researchers propose that the genome editing approach CRISPR could be used to treat forms of Alzheimer's disease caused by genetic mutations.
'CRISPR therapies could potentially be a one-and-done cure, which no other drug can match,' said Professor Subhojit Roy, a neuroscientist at the University of California, San Diego. But he added 'Cutting and pasting a gene is much harder to do in the brain using current technology.'